Thomas DiRaimondo insider trades

Open-market stock purchases and sales by Thomas DiRaimondo, Chief Scientific Officer at Janux Therapeutics, Inc, from SEC Form 4 filings since Jan 2, 2024.

Recent trades

DateStockTradeValue
Jan 2, 2026JANX Janux Therapeutics, IncSold$34.4K
Jan 2, 2026JANX Janux Therapeutics, IncBought (not open market)—
Jan 2, 2026JANX Janux Therapeutics, IncBought (not open market)—

Companies traded

  • JANX Janux Therapeutics, Inc: 3 sales, last Jan 2, 2026

Get free alerts when Thomas DiRaimondo files a new trade →